May 7, 2020 / 12:28 PM / a month ago

BRIEF-Intellia Therapeutics Inc - QTRLY Dhr Loss $0.63

Intellia Therapeutics Inc:

* INTELLIA THERAPEUTICS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS

* INTELLIA THERAPEUTICS INC - ON TRACK TO SUBMIT AN IND OR IND-EQUIVALENT FOR NTLA-2001 FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS IN MID-2020

* INTELLIA THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES AS OF MARCH 31, TO FUND OPERATING EXPENSES, CAPEX AT LEAST THROUGH END OF 2021

* INTELLIA THERAPEUTICS INC - QTRLY DHR LOSS $0.63 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below